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A B S T R A C T
Background: Staphylococcus aureus is a serious pathogen, able to cause life-threatening infections such as
bacteraemia. The association between S. aureus microbial characteristics and clinical outcomes is under-
investigated in African settings. This study aimed to determine the molecular epidemiology and virulence
characteristics of S. aureus isolates from bacteraemic patients at Tygerberg Hospital, South Africa, and to
investigate the associations between pathogen characteristics and clinical outcomes.
Methods: This study included 199 S. aureus isolates collected from blood cultures between February 2015
and March 2017. Methicillin resistance was determined using disc diffusion and all resistant isolates were
further characterized by staphylococcal cassette chromosome mec (SCCmec) typing. Genotyping was done
using spa and agr typing, and agr functionality was assessed using the phenotypic d-haemolysin assay.
Logistic regression models were performed to describe the associations between strain characteristics and
the clinical outcomes methicillin resistance, in-hospital mortality, and length of stay (LOS).
Results: Of the 199 S. aureus isolates collected, 27% were MRSA, and the overall crude in-hospital mortality
rate was 29%. Seventy-three different spa types were identified, including seven new types. Agr I was the
most common type, in 99 (49.7%) isolates, followed by agr II, III, and IV in 57 (28.6%), 37 (18.6%), and six (3%)
isolates, respectively. Agr dysfunctionality was observed in 25 (13%) isolates, mostly belonging to
spa-clonal complex (CC) 012. Methicillin resistance was significantly associated with hospital-acquired
infection (odds ratio (OR) 4.77, 95% confidence interval (CI) 2.09–10.87). A significant increase in mortality
was observed with increasing age (OR 7.48, 95% CI 2.82–19.8) and having a hospital-acquired infection (OR
2.26, 95% CI 1.12–4.55). S. aureus strains with a functional agr system showed an association with longer
duration of stay (OR 1.66, 95% CI 0.93–2.99).
Conclusions: We report the lowest MRSA prevalence at Tygerberg Hospital for the past 10 years, and agr
dysfunctionality was shown to be driven by a certain genotype, spa-CC012. Despite the limited available
clinical data, the study provided insights into associations between S. aureus epidemiology and agr-related
virulence characteristics, and clinical outcomes.
© 2019 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).
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license (http://creativecommons.org/licenses/by-nc-nd/4.0/).infections, such as abscesses and tissue invasion. It is a leading
cause of hospital-acquired (HA), healthcare-associated (HCA), and
community-acquired (CA) infections (Kaech et al., 2006; Perovic
et al., 2015). Invasive S. aureus infections can manifest in many
different ways, the most common manifestation being
bacteraemia (Turnidge et al., 2009). More than 80% of S. aureus
bacteraemia is endogenous in origin, which could be a result of the
high carriage rates among individuals (Kaech et al., 2006; von Eiff
et al., 2001). Bacteraemia caused by methicillin-resistant S. aureus
(MRSA) is associated with high mortality rates due to their
resistance to a wide range of antibiotics, including the last resort
agents, creating a therapeutic challenge (Bassetti et al., 2017).iety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
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expression of several virulence factors that contribute to S. aureus
infections, especially those that are toxin-related. Four different
agr types, I–IV, have been described based on sequence variation
within the hypervariable region of the agr locus (agrB, agrC, agrD)
(George and Muir, 2007). Some S. aureus strains have a
dysfunctional agr system due to genetic changes within the locus,
and in some cases, dysfunctionality may develop in vivo during
infection (Gagnaire et al., 2012). Agr dysfunctionality results in
failure to express the effector molecule RNAIII, which plays a
critical role in the downstream regulatory process, influencing the
production of virulence factors involved in invasive diseases
(George and Muir, 2007). Previous studies have reported that agr
types could be predictors of certain disease manifestations and
clinical outcomes (Lim et al., 2013; Yarwood and Schlievert, 2003).
For example, agr type I strains are more prevalent in HA infections
and are associated with resistance to glycopeptides (Robinson
et al., 2005; Sakoulas et al., 2002). Agr types III and IV have been
associated with toxic shock syndrome and staphylococcal scalded
skin syndrome, respectively (Robinson et al., 2005). It is therefore
essential to perform strain typing and virulence profiling to track
and manage the spread of infection (Earls et al., 2017). S. aureus
strains with a dysfunctional agr system have shown a fitness
advantage over functional strains, reflected in their ease of
transmission and persistence at the site of infection (Chong
et al., 2013; Sakoulas et al., 2009). Agr dysfunctional strains have
also been linked to deleterious outcomes such as persistent
bacteraemia, reduced susceptibility to vancomycin, and increased
mortality (Fowler et al., 2004; Sakoulas et al., 2006; Schweizer
et al., 2011).
In South Africa, limited data are available on the molecular
epidemiology and virulence factors of S. aureus strains involved in
S. aureus bacteraemia, and there is a lack of studies associating
these microbial factors with clinical outcomes. Therefore, this
study was performed to describe the S. aureus strains circulating at
Tygerberg Hospital and to investigate associations between
bacterial genetic background and virulence determinants and
methicillin resistance, mortality, and length of stay (LOS) among
bacteraemic patients.
Methods
This was a prospective study that included patients with
laboratory-confirmed S. aureus blood stream infections at Tyger-
berg Hospital, South Africa between January 2015 and March 2017.
Tygerberg Hospital is a 1384-bed tertiary academic hospital
serving a population of approximately 1.9 million in the Western
Cape, South Africa. Clinical and demographic data of patients
included in the study were collected as part of the routine
surveillance conducted by the Group for Enteric, Respiratory and
Meningeal Disease Surveillance in South Africa (GERMS-SA).
Bacterial identification
Blood cultures were submitted to the National Health
Laboratory Service (NHLS) microbiology laboratory at Tygerberg
Hospital at the discretion of attending clinicians, and as part of
the diagnostic investigation of patients presenting to the hospital.
S. aureus was identified from positive blood cultures using
standard microbiological methods: Gram morphology, catalase,
mannitol fermentation, and DNAse activity. Isolates with discrep-
ant or inconclusive results were further identified using the Vitek 2
Advanced Expert System (AES; bioMérieux, France). Methicillin
resistance was determined using cefoxitin disc diffusion, according
to Clinical and Laboratory Standards Institute (CLSI) standards(CLSI, 2015), and was confirmed using the Vitek 2 AES (bioMérieux,
France). Isolates were stored at 80 C.
Molecular characterization
Genomic DNA was extracted following an in-house heat lysis
protocol. All S. aureus isolates were genotyped using spa-typing
targeting the variable region of the spa gene (Harmsen et al., 2003)
Sequence analysis was performed using the Ridom StaphType
software (Munster, Germany), and allocation of the spa clonal
complexes (spa-CC) used the ‘based upon repeat pattern’ (BURP)
algorithm that is implemented within the software (Harmsen et al.,
2003; Strommenger et al., 2006). All MRSA were subjected to
staphylococcal cassette chromosome mec (SCCmec) typing using a
multiplex PCR (Milheiriço et al., 2007). At least one isolate from the
eight major spa-CC was selected for further characterization using
multilocus sequence typing (MLST), as described previously
(Enright et al., 2000).
Agr typing and functionality
The agr type was determined by multiplex PCR, as described
previously (Lina et al., 2003). Functionality of the agr system was
assessed using the phenotypic synergistic agr functionality assay
(Sakoulas et al., 2002). Briefly, the test isolates were streaked out
perpendicular to the β-haemolytic control strain S. aureus RN4220
on sheep blood agar plates (Green Point Media Lab, South Africa).
Agr functionality was assigned based on the presence of
d-haemolysis detected as enhanced or complete haemolysis
within the β-haemolysis zone of S. aureus RN4220. The strains
NRS155 and NRS149 were used as agr dysfunctional and functional
controls, respectively.
Clinical outcomes and definitions of variables
HA infections were defined as positive blood cultures taken
more than 3 days after hospital admission. HCA infections were
defined as positive blood cultures taken within 3 days of
admission, with one or more of the following risk factors present:
hospitalization, surgery, prior dialysis, or residence in a long-term
care facility, within the year prior to the current hospital
admission. CA infections were defined as positive blood cultures
taken at hospital admission or within 3 days of admission without
any of the above-mentioned risk factors (Perovic et al., 2017).
Bacteraemia cases with undetermined source were classified as
bacteraemia without focus. The patient outcomes that were
assessed included crude in-hospital mortality and LOS. LOS was
determined using the admission and final outcome (death or
discharge) dates.
Statistical analysis
Logistic regression models for categorical variables were
used to assess associations between the final outcomes of
mortality and methicillin resistance, and the other patient and
isolate covariates, using both univariable and multivariable
analyses. All variables with p-values of < 0.1 in the univariable
analysis were included in the logistic regression model
using stepwise elimination. Since LOS was a continuous variable,
the two-sample Wilcoxon rank sum (Mann–Whitney) test and
Cox proportional hazards model were used to assess associations
between LOS and the other variables. The statistical analysis
was done using Stata version 15 (StataCorp. LLC, College





Length of stay in days, median (IQR) 24 (11.5–46)
Final outcome (n = 193)
Died 58 (29.1%)
Age group (n = 199)
Neonates (<28 days) 21 (10.6%)
Children (28 days – <14 years) 32 (16.1%)
Adults (14 year – <50 years) 96 (48.2%)
Elderly (50 years) 50 (25.1%)
Sex (n = 193)
Male 113 (56.8%)
Diagnosis (n = 186)
Bacteraemia with focus 57 (28.6%)
Bacteraemia without focus 129 (64.8%)




IQR, interquartile range; HA, hospital-acquired infection; HCA, healthcare-
associated infection; CA, community-acquired infection.
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Patient characteristics and clinical outcomes
Between January 2015 and March 2017, 473 S. aureus
bacteraemia cases were documented by GERMS-SA at Tygerberg
Hospital. Of these, 199 non-duplicate S. aureus isolates were
collected from the NHLS microbiology laboratory. Clinical profiles
were missing for six of these 199 patients and were further
excluded from the statistical analyses. Table 1 summarizes the
participants’ characteristics. The median age of the patients was 30
years (interquartile range (IQR) 8.5–50 years), with the majority of
the patients (48%) being adults. The median LOS was 24 days
(IQR 11.5–46 days) and the overall crude mortality rate was 29%.
More than 50% of the infections were HA, and bacteraemia
without focus was the main diagnosis reported in this
study (Table 1).Table 2




CC 002 t002a, t045a, t071, t242, t509, t1154, t5213, t1530
CC 012 t012a, t018, t021, t037a, t318a, t399, t1848 
CC 701/2360 t190, t701, t1257, t1476a, t1971, t2360, t4315 
CC 032/578 t032a, t578, t891, t1036 
CC 015/073 t015a, t073, t116, t331, t1078, t2171 
CC 084 t084a, t085, t346, t14791, t18222 
CC NF 174 t127a, t174, t18225, t18227 
CC NF 9 t148a, t2409 
CC NF 5916 t1490, t5916, t18226 
CC NF 10 t317a, t6712a
CC NF 11 t1597, t11970 
CC NF 12 t258, t349 
Singletons t008, t091, t189, t223, t267, t269, t272, t355,
t888, t1467, t2442, t2526, t2763, t6267, t10509, t1
t18224, t18228
Excludedb t026, t2304, t9909, 
Non-typeable N/A 
MLST, multilocus sequence typing; ST, sequence type; NT, non-typeable by MLST; ND, no
types for each spa-CC are indicated in bold. New spa types are underlined.
a spa types selected for MLST.
b Excluded from the BURP clustering due to short number of repeats (<5 repeats).Molecular epidemiology of S. aureus isolates from blood samples
The prevalence of MRSA in this cohort was 27.1% (n = 54). A total
of 189 isolates (95%) were typeable by spa-typing, and 73 different
spa types were identified, including seven new types (t18222–
t18228) (Table 2). The BURP cluster analysis grouped the spa types
into 12 spa-CCs (n = 153; 77%) and 32 singletons. Of the 12 spa-CCs
identified, six contained only methicillin-susceptible S. aureus
(MSSA) isolates (spa-CC 015/037, spa-CC 084, spa-CC 174, spa-CC
NF10, spa-CC NF11, spa-CC NF12) and six (spa-CC002, spa-CC012,
spa-CC701/2360, spa-CC032/578, spa-CC5916, spa-CCNF9) con-
sisted of both MRSA and MSSA isolates. spa type t045 (spa-CC002)
was the most abundant, accounting for 11% (n = 22) of the typed
strains, most of which were methicillin-resistant (20/22, 91%). At
least one isolate from each of the larger spa-CC was selected for
further typing using MLST. The identified sequence types (STs)
belonged to the most common MLST CCs, namely, 5, 15, 22, 30, and
45 (Table 2). SCCmec typing was done on all MRSA strains and only
three isolates were non-typeable using the protocol of Milheiriço
et al. SCCmec type IV and a putative novel SCCmec variant (NV)
were each identified in 19 (35.2%) isolates. The NV had a similar
genetic structure to SCCmec type I, with an additional ccrC gene
(unpublished data). SCCmec type III (n = 7; 13%) was the third most
prevalent, followed by SCCmec type II (n = 6; 11.1%).
The MRSA clone t045-ST5-MRSA-NV accounted for 19 (35.2%) of
the MRSA isolates, followed by t037-ST239-MRSA-III and t032-
ST22-MRSA-IV, each accounting for seven (13%) MRSA isolates.
Clones t1257-MRSA-IV and t012-ST30-MRSA-II accounted for five
(9.3%) and four (7.4%) of the MRSA isolates, respectively. The
dominant MSSA clone was t318-ST1865 (n = 14/154; 9.7%),
followed by t002-ST5 (n = 13/154; 9%).
Agr typing and functionality
Agr typing was successful for all 199 isolates and agr I was the
most common type, identified in 99 (49.7%) isolates, followed by
agr II in 57 (28.6%) isolates and type III in 37 (18.6%) isolates. Only
six isolates (3%) were identified as agr IV. No difference was













23 8 (5) Mixed
13 22 (22) Mixed
10 508 (45) MSSA
10 15 (15) MSSA
7 1 (5) MSSA









t determined; MSSA, methicillin-susceptible Staphylococcus aureus. The founder spa
Table 3
Associations between agr type and functionality status and both clinical and microbial characteristics.
Characteristic Number Agr functionality, n (%) p-Valuea Agr types, n (%) p-Valuea
Functional Dysfunctional I II III IV
Methicillin resistance 54 44 (81) 10 (19) 0.12 27 (50) 20 (37) 7 (13) 0 0.15
Mortality 58 51 (88) 7 (12) 0.89 34 (59) 16 (28) 7 (12) 1 (1) 0.30
Bacteraemia 0.08 0.34
With focus 57 54 (93) 3 (7) 32 (56) 12 (21) 12 (21) 1 (2)
Without focus 129 111 (86) 18 (14) 59 (46) 43 (33) 23 (18) 4 (3)
Source of infection 0.78 0.21
HA 105 92 (88) 13 (12) 52 (50) 37 (35) 13 (12) 3 (3)
HCA 46 42 (91) 4 (9) 24 (52) 9 (20) 11 (23) 2 (5)
CA 39 34 (87) 5 (13) 17 (44) 10 (26) 11 (28) 1 (2)
Main spa-CCs 0.02 <0.01
CC002 42 7 (88) 5 (12) 0 42 (100) 0 0
CC012 34 22 (65) 12 (35) 8 (24) 0 26 (76) 0
CC701/2360 23 23 (100) 0 23 (100) 0 0 0
Singletons 32 29 (91) 3 (9) 25 (78) 3 (10) 2 (6) 2 (6)
Other spa-CC 54 49 (91) 5 (9) 32 (59) 10 (19) 9 (17) 3 (5)
HA, hospital-acquired infection; HCA, healthcare-associated infection; CA, community-acquired infection; CC, clonal complex. Significant associations are indicated in bold.
a Chi-square test.
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spa-CC701/2360 and CC002 were made up of only agr I and II,
respectively. CC012 was mostly represented by agr III, with only
24% of the isolates belonging to agr I (Table 3).
Based on the phenotypic synergistic haemolysis test, 25 (13%) of
the isolates had a dysfunctional agr system, of which 10 (40%) were
MRSA. The prevalence of agr dysfunctionality was highest among
agr type IV (33.3%; n = 2/6) isolates, followed by agr type III (32.4%;
n = 12/37), II (8.8%; n = 5/57), and I (6.1%; n = 6/99). An association
was observed between agr dysfunctionality and the spa-CCs
(p = 0.02). This was further interrogated by univariable logistic
regression, and spa-CC012 was the cluster driving this association,
with odds ratio (OR) 4.03 (95% confidence interval (CI) 1.25–12.9;
p = 0.01) compared to spa-CC002. The ORs for singletons and ‘other
spa-CCs’ were 0.7 (95% CI 0.16–3.4) and 0.58 (95% CI 0.56–2.1),
respectively. Agr dysfunctionality was twice as common amongst
patients diagnosed with bacteraemia without focus compared to
those with a known focus, although this finding was not
statistically significant (Table 3).
Associations between pathogen characteristics and clinical outcomes
Possible associations between S. aureus characteristics and
the clinical outcomes methicillin resistance, mortality, and LOS
were assessed (Table 4). Univariable analysis showed that neonates
were at higher risk of infection with a methicillin-resistant strain
than the older age groups. Methicillin resistance was significantly
associated with HA infection compared to CA infection (OR 4.77,
95% CI 2.09–10.87). A significant association was observed
between spa-CC002 and methicillin resistance, relative to all other
spa-CCs (except 012 and 701/2360) and singletons. A significant
increase in mortality was observed with increasing age and having
a HA infection. However, HCA infections were associated with a
longer LOS (OR 1.97, 95% CI 1.13–3.42) and HA infections with a
shorter LOS (OR 0.48, 95% CI 0.30–0.76) compared to CA infections.
S. aureus strains with a functional agr system showed an
association with longer duration of stay, but this did not reach
statistical significance (Table 4).
Discussion
This study provided a comprehensive epidemiological investi-
gation of S. aureus from bacteraemic patients at Tygerberg
Hospital, both at the molecular and the clinical level, making it
one of few studies to explore associations between S. aureusmicrobial characteristics and clinical outcomes within Southern
Africa.
The 27% MRSA prevalence reported from bacteraemic patients
in this study is lower than the 43% reported from similar patients at
Tygerberg Hospital during 2010 to 2012 (Karayem, 2014). A steady
decrease in the MRSA prevalence in the public sector hospitals in
the Western Cape is evident, with MRSA rates of 37%, 33%, and 24%
in 2012, 2015, and 2017, respectively (Crowther-Gibson et al., 2015,
2016; Perovic et al., 2015). This notable decrease in the MRSA
prevalence is possibly due to regular monitoring through surveil-
lance and proper management of antibiotic use within the public
healthcare settings in South Africa (Boyles et al., 2013; Crowther-
Gibson et al., 2015, 2016). Compared to public hospitals, data on the
prevalence of MRSA from the private sector in the Western Cape
are scarce; however, the two existing studies have reported 36%
national MRSA prevalence from bacteraemic patients during the
year 2006 (Brink et al., 2007) and 20% from a wide range of clinical
samples from Cape Town centres during 2013 (Wasserman et al.,
2014). These findings might also reflect a decrease in the MRSA
prevalence in the private sector in South Africa; however, more
surveillance studies are required to confirm this speculation.
Overall, the prevalence of MRSA across the African continent is
lower than 50%, with Egypt (52–82%) and Algeria (35–75%) being
the exceptions (Falagas et al., 2013).
As expected, more strain diversity was observed amongst
methicillin-susceptible isolates as determined by spa-typing, which
is in agreement with previous reports (Grundmann et al., 2014;
Miko et al., 2013; Park et al., 2017; Pérez-Montarelo et al., 2018). On
the other hand, globally predominant MRSA clones were circulating
in our setting. The clone t045-ST5-MRSA, which was isolated during
an outbreak in the neonatal and paediatric wards, accounted for 35%
of the isolates and it carried a putative novel SCCmec type
(unpublished data). This clone has been described previously
across South Africa, but has been linked to various SCCmec types,
supporting the ease of transmissibility and recombination of this
mobile geneticelement through horizontal gene transfer (Essa et al.,
2009; Jansen van Rensburg et al., 2011; Perovic et al., 2015; Shittu
et al., 2009). In addition, we noted the presence of the pandemic
clone t037-ST239-MRSA-III (CC5), also known as the Brazilian/
Hungarian clone, which seems to be endemic across South African
hospitals (Abdulgader et al., 2015). Although not selected for MLST,
the strain type t1257-MRSA-IV has been associated with the local
clone ST612, which has been shown to be dominant in other
hospitals in South Africa since 2008, but it was infrequent in this
study (Jansen van Rensburg et al., 2011; Perovic et al., 2015).
Table 4
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0.663 1.00 – –





0.127 – 1.66 (0.93– 2.99) 0.089
OR, odds ratio; CI, confidence interval; MRSA, methicillin-resistant Staphylococcus aureus; CA, community-acquired infection; HA, hospital-acquired infection; HCA,
healthcare-associated infection.
a The analysis of length of stay was done by two-sample Wilcoxon rank sum test for continuous variables and the Kruskal–Wallis equality of populations rank test for the
univariable analysis, and by Cox proportional hazards regression for the multivariable analysis. Significant associations from the multivariable analyses are highlighted in
bold.
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Africa and Australia, suggesting possible introductions through
travel between these two countries (Jansen van Rensburg et al.,
2011; Murphy et al., 2019).
Agr type I was the most predominant (50%), followed by types II
(29%) and III (19%), while agr type IV was rare in our setting. This
distribution may be driven by the genotypes circulating within the
hospital, as the agr locus is strongly linked to the bacterial genetic
background and may reflect the molecular epidemiology of
S. aureus within a setting (Lina et al., 2003). This was well
demonstrated by the study data, since all of the isolates
representing spa-CC701/2360 and CC002 belonged to agr types
II and III, respectively. However, we noted an exception: spa-CC012
consisted of 75% agr type III and 25% agr type II. Evolution studies
proved that MLST CC30 is the genetic background for spa-CC012,
which belongs to agr type III (Monecke et al., 2011). However, 25%
of this cluster (spa-CC012) was represented by spa type t037
(ST239), which has evolved by recombination of a 557-kb fragment
from the chromosome of ST30 into a ST8 (CC5) background that
belongs to agr type I (David, 2019; Deurenberg and Stobberingh,
2008).
Animal models have demonstrated the importance of a
functional agr system for the pathogenesis of S. aureus; however,the isolation of S. aureus with low-level agr expression, or
sometimes a defective agr system from or during clinical
infections, questions its role in pathogenesis in humans (Gagnaire
et al., 2012; Gong et al., 2014). In this study, only 13% of the isolates
had a dysfunctional agr system and this seemed to be driven by a
single cluster (spa-CC012). The prevalence of agr dysfunctionality
reported amongst bacteraemic patients in previous studies has
varied between 10% and 32% (Butterfield et al., 2011; Gagnaire
et al., 2012; Schweizer et al., 2011). In the United States, 22% agr
dysfunctionality was reported in severely ill patients (as measured
by acute physiology score) with S. aureus bacteraemia (Schweizer
et al., 2011). Another study by Butterfield and co-workers, also in
the United States, reported a prevalence of 32% agr dysfunction-
ality; however, the study only targeted patients with MRSA
bacteraemia, which explains the higher prevalence, as agr
dysfunctionality has previously been associated with MRSA
(Butterfield et al., 2011). Comparing these findings across studies
should be done with caution, since factors such as age, severity of
illness, and previous exposure to antibiotics or healthcare settings,
could impact the prevalence of agr dysfunctionality. Agr dysfunc-
tionality was more abundant among the isolates belonging to
spa-CC012, in contrast to a study by Shopsin et al., who reported
that agr functionality is not clone-specific in isolates from healthy
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reflects mostly nosocomial isolates; therefore the predominance of
certain strains due to selection pressure in hospital settings is to be
expected (Stefani et al., 2012). Agr dysfunctionality was not
associated with MRSA, contradicting studies from France and
Korea (Gagnaire et al., 2012; Jang et al., 2012). This could be
explained by the high predominance of SCCmec type IV in this
study, since agr dysfunctionality has been reported to be less
frequent amongst isolates carrying this element compared to
SCCmec types I–III (Jang et al., 2012; Kang et al., 2015).
A highlight of this study is the assessment of possible
associations between the pathogen-related characteristics and
clinical data. This is critical, since it facilitates the identification of
institution-specific risk factors, which can be used to develop
processes to monitor dissemination of virulent pathogens and
guide empirical antibiotic therapy decisions (Butterfield et al.,
2011). This study assessed the possible predictors for three main
clinical outcomes: crude mortality, LOS, and methicillin resistance.
Older age and HA infections were the only independent risk factors
for mortality. This is not surprising, since older patients are
considered a high risk group with possibly impaired immune
systems and underlying comorbidities (Albur et al., 2012; McGarry
et al., 2004). In keeping with this, Malani et al. suggested that with
every decade increase in age, the odds of death within 6 months
due to S. aureus blood stream infection doubles (Malani et al.,
2008). HA infections are mostly associated with higher antibiotic
resistance rates, which may result in treatment failure leading to
death (Ignacio Barrasa-Villar et al., 2017). This is also supported by
the present study results, since HA infections were significantly
associated with methicillin resistance, which is usually linked to
resistance to a wider range of other antibiotics (Ignacio Barrasa-
Villar et al., 2017; Malani et al., 2008). In addition, methicillin
resistance was associated with spa-CC002, which is evident in the
reduced odds of being methicillin-resistant amongst the singletons
and the ‘other’ spa-CCs compared to spa-CC002. This association
was driven by the clone t045-MRSA-NV, representing more than a
third of the total methicillin-resistant isolates, which was
dominant during a neonatal outbreak at Tygerberg Hospital
during the study period.
Interestingly, no significant associations were found between
any of the other pathogen-related characteristics and clinical
outcomes studied, except for methicillin resistance. Although not
reaching statistical significance, patients who had bacteraemia of
unknown source were more likely to be infected with a
dysfunctional isolate compared to patients with a definitive
diagnosis. Agr dysfunctionality has been reported as an indepen-
dent risk factor for bacteraemia and in-hospital mortality in
patients with persistent MRSA bacteraemia in the United States
and South Korea (Kang et al., 2017; Schweizer et al., 2011).
However, these studies were conducted in settings with higher
rates of agr dysfunctionality (22% and 32%). We further noted a
trend towards a shorter LOS for patients infected with agr
dysfunctional strains. Although a few studies suggested that agr
dysfunctionality has been associated with worse clinical outcomes
such as treatment failure and increased mortality, the body of
literature remains conflicted regarding the effect of agr dysfunc-
tionality on clinical outcomes (Gomes-Fernandes et al., 2017;
McDanel et al., 2015; Schweizer et al., 2011). The association
between agr dysfunctionality and shorter LOS remains to be
investigated; however, the small proportion of agr dysfunctional
isolates in this study in addition to the overall lengthy duration of
hospital stay in our setting (median of 24 days) might have skewed
these data.
Limitations of this study are mainly related to the incomplete
clinical data collected from patients. Also, we were not able to
analysetheeffectofpriorantibioticexposureonagrdysfunctionality,which has been shown to be a predictor for infection by
dysfunctional isolates; patients who received a prior β-lactam or
fluoroquinolone were twice as likely to be infected with an agr
dysfunctional versus functional isolate (Butterfield et al., 2011).
In conclusion, we report the lowest MRSA prevalence at
Tygerberg Hospital for the past 10 years, and agr dysfunctionality
was shown to be more predominant amongst the spa-CC012
cluster. Despite the limited available clinical data, the study
provided insights into the association between S. aureus epidemi-
ology and agr-related virulence characteristics, and clinical out-
comes.
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